We have located links that may give you full text access.
Congress Enters Contentious Debate on Biosimilar Naming: Bill Provision Sides With Brand-Name Companies Over USP.
P & T : a Peer-reviewed Journal for Formulary Management 2016 September
Congress set to tackle biosimilar naming debate.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app